{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:11:25Z","timestamp":1785787885967,"version":"3.56.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003330","name":"Secretaria de Estado de Investigacion Desarrollo e Innovacion","doi-asserted-by":"publisher","award":["PID2022\\u2013140602NB-I00"],"award-info":[{"award-number":["PID2022\\u2013140602NB-I00"]}],"id":[{"id":"10.13039\/501100003330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003330","name":"Secretaria de Estado de Investigacion Desarrollo e Innovacion","doi-asserted-by":"publisher","award":["SBPLY \/23\/180225\/000156"],"award-info":[{"award-number":["SBPLY \/23\/180225\/000156"]}],"id":[{"id":"10.13039\/501100003330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011698","name":"Junta de Comunidades de Castilla-La Mancha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031557","name":"Diputaci\u00f3n de Albacete","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031557","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007480","name":"Universidad de Castilla-La Mancha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.colsurfb.2026.115827","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:53:40Z","timestamp":1779173620000},"page":"115827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nanotechnology-based encapsulation of neflamapimod: A new therapeutic strategy for lewy body dementia"],"prefix":"10.1016","volume":"266","author":[{"given":"Maria Paz","family":"Garc\u00eda-Simarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Genicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ba\u00f1obre-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Baselga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Martinez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaira","family":"Llaneza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Albasanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairena","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2845-4509","authenticated-orcid":false,"given":"Enrique","family":"Niza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.colsurfb.2026.115827_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-021-00501-z","article-title":"Neuropathology and molecular diagnosis of Synucleinopathies","volume":"16","author":"Koga","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"no. June","key":"10.1016\/j.colsurfb.2026.115827_bib2","article-title":"Learning to PERSEVERE: A pilot study of peer mentor support and caregiver education in Lewy body dementia","volume":"113","author":"Fleisher","year":"2023","journal-title":"Park. Relat. Disord."},{"issue":"no. October","key":"10.1016\/j.colsurfb.2026.115827_bib3","article-title":"Neuropathological evidence of body-first vs. brain-first Lewy body disease","volume":"161","author":"Borghammer","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"no. December 2023","key":"10.1016\/j.colsurfb.2026.115827_bib4","article-title":"Sleep disorders and Alzheimer\u2019s disease pathophysiology: The role of the Glymphatic System. A scoping review","volume":"217","author":"Astara","year":"2024","journal-title":"Mech. Ageing Dev."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115827_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.colsurfb.2026.115827_bib6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.neurol.2022.03.008","article-title":"Biomarkers and diagnosis of dementia with Lewy bodies including prodromal: Practical aspects","volume":"178","author":"Blanc","year":"2022","journal-title":"Rev. Neurol. (Paris)."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115827_bib7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s40120-023-00467-8","article-title":"Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022","volume":"12","author":"Abdelnour","year":"2023","journal-title":"Neurol. Ther."},{"issue":"11","key":"10.1016\/j.colsurfb.2026.115827_bib8","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1021\/acschemneuro.3c00205","article-title":"Synthesis and Preclinical Positron Emission Tomography Imaging of the p38 MAPK Inhibitor [11C]Talmapimod: Effects of Drug Efflux and Sex Differences","volume":"14","author":"Chass\u00e9","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.colsurfb.2026.115827_bib9","series-title":"Nanotechnology in Parkinson\u2019s Disease: overcoming drug delivery challenges and enhancing therapeutic outcomes","first-page":"0123456789","author":"Ali","year":"2025"},{"issue":"no. November 2025","key":"10.1016\/j.colsurfb.2026.115827_bib10","article-title":"Cytotoxicity potential of basil oil embedded 5-fluorouracil-phospholipid complex loaded self-nanoemulsifying system: Design expert \u00ae endorsed approach for bioavailability enhancement","volume":"441","author":"Kumar","year":"2026","journal-title":"J. Mol. Liq."},{"issue":"no. August","key":"10.1016\/j.colsurfb.2026.115827_bib11","first-page":"1","article-title":"Parkinson\u2019s disease: a nanotheranostic approach targeting alpha-synuclein aggregation","volume":"9","author":"Zoey","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115827_bib12","doi-asserted-by":"crossref","first-page":"e21789","DOI":"10.1016\/j.heliyon.2023.e21789","article-title":"Heliyon Cerium oxide nanoparticles modulating the Parkinson \u2019 s disease conditions: From the alpha synuclein structural point of view and antioxidant properties of cerium oxide nanoparticles","volume":"10","author":"Yao","year":"2024","journal-title":"Heliyon"},{"issue":"9","key":"10.1016\/j.colsurfb.2026.115827_bib13","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41565-018-0179-y","article-title":"Graphene quantum dots prevent \u03b1-synucleinopathy in Parkinson\u2019s disease","volume":"13","author":"Kim","year":"2018","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115827_bib14","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.nano.2018.01.020","article-title":"Neuroprotective effect of gold nanoparticles composites in Parkinson\u2019s disease model","volume":"14","author":"Hu","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"no. December","key":"10.1016\/j.colsurfb.2026.115827_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.omtn.2017.08.013","article-title":"Polyethylenimine nanoparticle-mediated siRNA delivery to reduce \u03b1-synuclein expression in a model of Parkinson\u2019s disease","volume":"9","author":"Helmschrodt","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"no. August 2018","key":"10.1016\/j.colsurfb.2026.115827_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainres.2018.11.034","article-title":"ScFv-conjugated superparamagnetic iron oxide nanoparticles for MRI-based diagnosis in transgenic mouse models of Parkinson\u2019s and Huntington\u2019s diseases","volume":"1707","author":"Liu","year":"2019","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115827_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejps.2012.12.007","article-title":"Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: Pharmacodynamic, Pharmacokinetic and Scintigraphy study in mice model","volume":"48","author":"Shadab","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"15","key":"10.1016\/j.colsurfb.2026.115827_bib18","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1016\/j.biomaterials.2013.02.003","article-title":"Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration","volume":"34","author":"Liu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2026.115827_bib19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2147\/IJN.S151474","article-title":"Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer\u2019s disease","volume":"vol. 13","author":"Meng","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2026.115827_bib20","first-page":"1","article-title":"TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer \u2019 s disease patients","author":"Martinez-gonzalez","year":"2023","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.colsurfb.2026.115827_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jece.2025.117763","article-title":"Two novel eco-friendly seed dressing nano-antifungals based on pH-responsive dendritic silica nanoparticles coated with chitosan and polydopamine","volume":"13","author":"Garc\u00eda-Simarro","year":"2025","journal-title":"J. Environ. Chem. Eng."},{"issue":"no. February","key":"10.1016\/j.colsurfb.2026.115827_bib22","article-title":"PEI-coated PLA nanoparticles to enhance the antimicrobial activity of carvacrol","volume":"328","author":"Niza","year":"2020","journal-title":"Food Chem."},{"key":"10.1016\/j.colsurfb.2026.115827_bib23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jcis.2016.10.093","article-title":"Rapid microwave-assisted synthesis of sub-30 nm lipid nanoparticles","volume":"488","author":"Dunn","year":"2017","journal-title":"J. Colloid Interface Sci."},{"issue":"no. April","key":"10.1016\/j.colsurfb.2026.115827_bib24","article-title":"Liposomal encapsulation of crocin-rich tomato extract (Tomafran) and its in-depth evaluation as a cosmeceutical ingredient","volume":"253","author":"Mond\u00e9jar-L\u00f3pez","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115827_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.colsurfb.2026.115827_bib26","first-page":"1","article-title":"Combination chemotherapy via poloxamer 188 surface \u2011 modified PLGA nanoparticles that traverse the blood \u2013 brain \u2013 barrier in a glioblastoma model","author":"Madani","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.colsurfb.2026.115827_bib27","doi-asserted-by":"crossref","unstructured":"K. Zhi, , 2021, PLGA Nanoparticle-Based Formulations to Cross the Blood \u2013 Brain Barrier for Drug Delivery\u00a0: From R & D to cGMP, pp. 1\u201317.","DOI":"10.3390\/pharmaceutics13040500"},{"key":"10.1016\/j.colsurfb.2026.115827_bib28","doi-asserted-by":"crossref","unstructured":"M. Pachitariu, M. Rariden, C. Stringer, 2025, Cellpose-SAM: superhuman generalization for cellular segmentation,\u201d 2025.","DOI":"10.1101\/2025.04.28.651001"},{"key":"10.1016\/j.colsurfb.2026.115827_bib29","first-page":"1","article-title":"CellProfiler 4: improvements in speed, utility and usability","author":"Stirling","year":"2021","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.colsurfb.2026.115827_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2017.00235","article-title":"Microglia morphological categorization in a rat model of neuroinflammation by hierarchical cluster and principal components analysis","volume":"11","author":"Fern\u00e1ndez-arjona","year":"2017","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.colsurfb.2026.115827_bib31","doi-asserted-by":"crossref","unstructured":"V. Rocha, V. Gon\u00e7alves, M. Costa, M. Ba\u00f1obre-l, J. GalloPLGA-Based Composites for Various Biomedical Applications2022.","DOI":"10.3390\/ijms23042034"},{"issue":"11","key":"10.1016\/j.colsurfb.2026.115827_bib32","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.clinthera.2023.08.017","article-title":"Use of Silica Nanoparticles for drug delivery in cardiovascular disease","volume":"45","author":"Kirla","year":"2023","journal-title":"Clin. Ther."},{"issue":"no. June","key":"10.1016\/j.colsurfb.2026.115827_bib33","article-title":"Multifunctional mesoporous silica nanoparticles for biomedical applications","author":"Xu","year":"2023","journal-title":"Signal Transduct. Target. Ther. Vol."},{"issue":"no. November 2022","key":"10.1016\/j.colsurfb.2026.115827_bib34","article-title":"Current status of silica-based nanoparticles as therapeutics and its potential as therapies against viruses","volume":"210","author":"Jian","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.colsurfb.2026.115827_bib35","unstructured":"A.C. Anselmo, S. MitragotriNanoparticles in the clinic: An update no. August2019, 11610.1002\/btm2.10143."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115827_bib36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/17435889.2026.2615102","article-title":"Designing drug delivery systems: the impact of structural order and disorder for optimized therapeutic outcomes optimized therapeutic outcomes","volume":"21","author":"Masoero","year":"2026","journal-title":"Nanomedicine"},{"issue":"no. August","key":"10.1016\/j.colsurfb.2026.115827_bib37","article-title":"Materials Today Bio Structure-centered design of lipid-based nanocarriers to overcome biological barriers","volume":"35","author":"Woo","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.colsurfb.2026.115827_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jconrel.2007.12.013","article-title":"Temoporfin-loaded invasomes: Development, characterization and in vitro skin penetration studies","volume":"127","author":"Dragicevic-curic","year":"2008","journal-title":"J. Controlled Release"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115827_bib39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00432-022-04387-2","article-title":"Role of natural P \u2011 gp inhibitor in the effective delivery for chemotherapeutic agents","volume":"149","author":"Shah","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.colsurfb.2026.115827_bib40","unstructured":"T. Nguyen, V. DuongPharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability 48 12021."},{"issue":"6","key":"10.1016\/j.colsurfb.2026.115827_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/smll.202304670","article-title":"The Stokes\u2013Einstein\u2013Sutherland Equation at the Nanoscale Revisited","volume":"20","author":"Baer","year":"2024","journal-title":"Small"},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115827_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nano9121793","article-title":"Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer","volume":"9","author":"Niza","year":"2019","journal-title":"Nanomaterials"},{"issue":"no. September","key":"10.1016\/j.colsurfb.2026.115827_bib43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2018.09.004","article-title":"Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis","volume":"288","author":"Kurniawan","year":"2018","journal-title":"J. Control. Release"},{"issue":"23","key":"10.1016\/j.colsurfb.2026.115827_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adhm.201900965","article-title":"PLGA Porous Microspheres Dry Powders for Codelivery of Afatinib-Loaded Solid Lipid Nanoparticles and Paclitaxel: Novel Therapy for EGFR Tyrosine Kinase Inhibitors Resistant Nonsmall Cell Lung Cancer","volume":"8","author":"Yang","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.colsurfb.2026.115827_bib45","article-title":"\u201cInvasomes and Nanostructured Lipid Carriers for Targeted Delivery of Ceftazidime Combined with N-Acetylcysteine","author":"Josef","year":"2025","journal-title":"A Nov. Approach Treat. Pseudomonas aeruginosa -Induc. Keratitis"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115827_bib46","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1080\/10717544.2022.2072412","article-title":"Optimized 2-methoxyestradiol invasomes fortified with apamin: a promising approach for suppression of A549 lung cancer cells","volume":"29","author":"Awan","year":"2022","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115827_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-01008-x","article-title":"Mithramycin delivery systems to develop effective therapies in sarcomas","volume":"19","author":"Estupi\u00f1\u00e1n","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115827_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12100986","article-title":"Controlled delivery of bet-protacs: In vitro evaluation of MZ1-loaded polymeric antibody conjugated nanoparticles in breast cancer","volume":"12","author":"Cimas","year":"2020","journal-title":"Pharmaceutics"},{"issue":"no. August","key":"10.1016\/j.colsurfb.2026.115827_bib49","article-title":"Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines","volume":"233","author":"Ahmed","year":"2020","journal-title":"Chem. Phys. Lipids"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115827_bib50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/acsabm.9b00772","article-title":"Controlled Tyrosine Kinase Inhibitor Delivery to Liver Cancer Cells by Gate-Capped Mesoporous Silica Nanoparticles","volume":"3","author":"Sedighi","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.colsurfb.2026.115827_bib51","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.actbio.2016.05.012","article-title":"PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy","volume":"39","author":"Choi","year":"2016","journal-title":"Acta Biomater."},{"issue":"no. July","key":"10.1016\/j.colsurfb.2026.115827_bib52","article-title":"Evaluating the efficacy of nintedanib-invasomes as a therapy for non-small cell lung cancer","volume":"214","author":"Mahmoud","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115827_bib53","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.xphs.2024.10.032","article-title":"Impact of sink conditions on drug release behavior of controlled-release formulations","volume":"114","author":"Hate","year":"2025","journal-title":"J. Pharm. Sci."},{"issue":"no. June","key":"10.1016\/j.colsurfb.2026.115827_bib54","article-title":"Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier","volume":"66","author":"Seko","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2026.115827_bib55","unstructured":"E. Lauwaert, D. De Canck, J.W. Esquivel, Thybaut, 2014, Silanol-Assisted Aldol Condensation on Aminated Silica: Understanding the Arrangement of Functional Groups25526410.1002\/cctc.201300742."},{"issue":"6","key":"10.1016\/j.colsurfb.2026.115827_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13205-025-04364-9","article-title":"pH \u2011 responsive silica nanocarriers of olaparib for augmenting anticancer activity: development, characterization, and in vitro cytotoxicity study against MCF \u2011 7 breast cancer cells","volume":"15","author":"Gupta","year":"2025","journal-title":"3 Biotech"},{"key":"10.1016\/j.colsurfb.2026.115827_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/s11671-024-04157-8","article-title":"Discover Nano Solid lipid nanoparticles for increased oral bioavailability of acalabrutinib in chronic lymphocytic leukaemia","author":"Sinha","year":"2024","journal-title":"Discov. Nano"},{"key":"10.1016\/j.colsurfb.2026.115827_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/alz70861_107968","article-title":"A transcriptomic approach to characterize human monocyte-derived microglia-like cells as a potential tool for identifying biological markers of mild cognitive impairment","volume":"21","author":"Vald\u00e9s-tovar","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.colsurfb.2026.115827_bib59","doi-asserted-by":"crossref","unstructured":"P. Crivori, G. Cruciani, P. Carrupt, B. Testa, 2000, Predicting Blood - Brain Barrier Permeation from Three-Dimensional Molecular Structure,\u201d vol. 110, no. Table 1, pp. 2204\u20132216.","DOI":"10.1021\/jm990968+"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115827_bib60","doi-asserted-by":"crossref","DOI":"10.1007\/s13659-023-00425-9","article-title":"Neuroprotective properties of exosomes and chitosan nanoparticles of Tomafran, a bioengineered tomato enriched in crocins","volume":"14","author":"Etxebeste-Mitxeltorena","year":"2024","journal-title":"Nat. Prod. Bioprospect."},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115827_bib61","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrm2236","article-title":"The third dimension bridges the gap between cell culture and live tissue","volume":"8","author":"Pampaloni","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"no. December 2024","key":"10.1016\/j.colsurfb.2026.115827_bib62","first-page":"1","article-title":"Involvement of p38 MAPK and MAPKAPK2 in promoting cell death and the in fl ammatory response to ischemic stress associated with necrotic glioblastoma","author":"Kim","year":"2025","journal-title":"Cell Death Dis."},{"issue":"no. 848","key":"10.1016\/j.colsurfb.2026.115827_bib63","article-title":"Poly-GR repeats associated with ALS\/FTD gene C9ORF72 impair translation elongation and induce a ribotoxic stress response in neurons","volume":"17","author":"Dong","year":"2024","journal-title":"induce a ribotoxic Stress Response Neurons"},{"key":"10.1016\/j.colsurfb.2026.115827_bib64","unstructured":"Y. Goel, D.A. Argueta, K. Peterson, N. Lomeli, D.A. Bota, K. GuptaNeuronal p38 MAPK Signaling Contributes to Cisplatin-Induced Peripheral Neuropathy 19 12025."},{"key":"10.1016\/j.colsurfb.2026.115827_bib65","doi-asserted-by":"crossref","unstructured":"J. Ye, X. Dai, C. Zhang, Z. Duan, G. ZhouInvestigating the causal relationships between mitochondrial proteins and dementia with Lewy bodies,\u201d vol. 105, no. 2, pp. 378\u2013386, 2025, 10.1177\/138728772513288822025.","DOI":"10.1177\/13872877251328882"},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115827_bib66","doi-asserted-by":"crossref","first-page":"16189","DOI":"10.1007\/s12035-025-05241-5","article-title":"Formulation and evaluation of astaxanthin \u2011 loaded invasomes as therapeutic approaches for Alzheimer \u2019 s disease induced in rats: role of SIRT \u2011 1 \/ BDNF \/ miRNA \u2011 134 \/ GSK \u2011 3\u03b2 signaling","volume":"62","author":"Razik","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115827_bib67","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1007\/s13346-024-01534-9","article-title":"Resveratrol \u2011 loaded invasome gel: a promising nanoformulation for treatment of skin cancer","volume":"14","author":"Samir","year":"2024","journal-title":"Drug Deliv. Transl. Res."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526004157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526004157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:16:52Z","timestamp":1785784612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776526004157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":67,"alternative-id":["S0927776526004157"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115827","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanotechnology-based encapsulation of neflamapimod: A new therapeutic strategy for lewy body dementia","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115827","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115827"}}